vip236
vincerx pharma
['vip236']
vincerx pharma presents preclinical data on vip236, a first-in-class small molecule drug conjugate (smdc), at the 2023 american association for cancer research (aacr) annual meeting 
We provide a balanced view on small cap biotech equities.